Buprenorphine and Methadone Maintenance Treatment - Sexual Behaviour and Dysfunction Prevalence

被引：10
|
作者：
Giacomuzzi, S. M. [1 ]
Khreis, A.
Riemer, Y. [1 ]
Garber, K. [2 ]
Ertl, M. [1 ]
机构：
[1] Med Univ Innsbruck, Univ Dept Psychiat & Psychotherapy, Univ Clin Psychiat & Social Psychiat, Innsbruck Gen Hosp, A-6020 Innsbruck, Austria
[2] Free Univ Bozen, Bolzano, Italy
来源：
LETTERS IN DRUG DESIGN & DISCOVERY | 2009年 / 6卷 / 01期
关键词：
Substituion; Methadone; Buprenorphine; Sexuality; Dysfunction prevalence;
D O I：
10.2174/157018009787158580
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Buprenorphine maintenance treatment has become a major intervention in the care and treatment of drug dependence in Europe. Still little is known about sexual behaviour and sexual dysfunction especially under buprenorphine or methadone maintenance treatment. Our study aimed to evaluate patterns of sexual behaviour and dysfunction prevalence within buprenorphine and methadone maintenance treatment. Significant differences between both groups could be observed regarding sexual excitation disturbances and ability to orgasm. 33.3% of the methadone-maintained group showed significantly higher sexual excitation disturbances (p = 0.006). Future studies of sexual dysfunction in opioid-treated persons should examine the potential benefits of dose reduction, androgen replacement, and choice of opioid.
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [31] Comparing methadone and buprenorphine maintenance with methadone-assisted withdrawal for the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes
    Lund, Ingunn O.
    Fitzsimons, Heather
    Tuten, Michelle
    Chisolm, Margaret S.
    O'Grady, Kevin E.
    Jones, Hendree E.
    SUBSTANCE ABUSE AND REHABILITATION, 2012, 3 : 17 - 25
  • [32] Sexual Dysfunction among Male Patients Receiving Buprenorphine and Naltrexone Maintenance Therapy for Opioid Dependence
    Ramdurg, Santosh
    Ambekar, Atul
    Lal, Rakesh
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 (12) : 3198 - 3204
  • [33] Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: Prevalence estimates and risk factors
    Johnson, Bjorn
    Richert, Torkel
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (02) : 183 - 190
  • [34] Quality of life and associated factors of heroin-dependent patients receiving methadone and buprenorphine maintenance treatment
    Chang, Hu-Ming
    Huang, Ming-Chyi
    Fang, Su-Chen
    Lin, Shih-Ku
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2023, 43 (04) : 607 - 615
  • [35] Long-term replacement of methadone by equipotent buprenorphine for male heroin addicts with methadone-induced hyperprolactinaemia and sexual dysfunction. A case report
    Pacini, Matteo
    Maremmani, Angelo Giovanni Icro
    Rovai, Luca
    Bacciardi, Silvia
    Rugani, Fabio
    Maremmani, Icro
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2013, 15 (04) : 21 - 23
  • [36] Community based buprenorphine micro-induction in the context of methadone maintenance treatment and fentanyl - Case report
    Kaliamurthy, Sivabalaji
    Jegede, Oluwole
    Hermes, Gretchen
    JOURNAL OF ADDICTIVE DISEASES, 2023, 41 (02) : 175 - 180
  • [37] Attitudes and knowledge of substance misusers regarding buprenorphine and methadone maintenance therapy
    Pinto, H.
    Rumball, D.
    Holland, R.
    JOURNAL OF SUBSTANCE USE, 2008, 13 (03) : 143 - 153
  • [38] Buprenorphine versus methadone maintenance treatment in an ambulant setting:: a health-related quality of life assessment
    Giacomuzzi, SM
    Riemer, Y
    Ertl, M
    Kemmler, G
    Rössler, H
    Hinterhuber, H
    Kurz, M
    ADDICTION, 2003, 98 (05) : 693 - 702
  • [39] Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France
    Guichard, A
    Lert, F
    Calderon, C
    Hind, G
    Maguet, O
    Soletti, J
    Brodeur, JM
    Richard, L
    Benigeri, M
    Zunzunegui, MV
    ADDICTION, 2003, 98 (11) : 1585 - 1597
  • [40] Inflammatory, oxidative stress and cognitive functions in patients under maintenance treatment with methadone or buprenorphine and healthy subjects
    Arezoomandan, Mohammad
    Zhiani, Rahele
    Mehrzad, Jamshid
    Motavalizadehkakhky, Alireza
    Eshrati, Sahar
    Arezoomandan, Reza
    JOURNAL OF CLINICAL NEUROSCIENCE, 2022, 101 : 57 - 62
12345